Qingli Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingli Huang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Meng Wang
Public Experimental Research Center, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
3 shared publicationsQingli Huang
Department of Pathology, Laboratory of Clinical and Experimental Pathology, Xuzhou Medical University, Xuzhou, China
2 shared publicationsTing Li
Research Facility Center for Morphology of Xuzhou Medical University, Xuzhou, China
2 shared publicationsYanyan Tang
The First Clinical Medical College, Xuzhou Medical University, Xuzhou, Jiangsu 221004, China
2 shared publicationsBaolong Li
Public Experimental Research Center, Xuzhou Medical University, Xuzhou City, China
1 shared publicationChang Song
School of Pharmacy, Xuzhou Medical University, Xuzhou City, Jiangsu 221004, China
1 shared publication
Latest Publications
- Open Access
- 22 August 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (37) , 23786-23795
Synthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanocomposites for anti-cancer treatment
Manganese-oxide and palladium nanoparticle-co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanoenzyme composites were synthesized, and could be as a novel “theranostic nanoagent” for cancer treatment due to excellent performance.
- 22 August 2022
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 12 (37) , 23786-23795
Open AccessSynthesis of manganese-oxide and palladium nanoparticles co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanocomposites for anti-cancer treatment
Manganese-oxide and palladium nanoparticle-co-decorated polypyrrole/graphene oxide (MnO2@Pd@PPy/GO) nanoenzyme composites were synthesized, and could be as a novel “theranostic nanoagent” for cancer treatment due to excellent performance.
- Open Access
- 24 February 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (15) , 8420-8429
Fluorescence imaging-guided cancer photothermal therapy using polydopamine and graphene quantum dot-capped Prussian blue nanocubes
In recent years, imaging-guided photothermal tumor ablation has attracted intense research interest as one of the most exciting strategies for cancer treatment. Herein, we prepared polydopamine and graphene quantum dot-capped Prussian blue nanocubes (PB@PDA@GQDs, PBPGs) with high photothermal conversion efficiency and excellent fluorescence performance for imaging-guided cancer treatment. Transmission electron microscopy (TEM), UV-vis absorption spectroscopy (UV-vis), fluorescence spectroscopy, and X-ray photoelectron spectroscopy (XPS) were employed to characterize their morphology and structures. The photothermal conversion efficiency and therapeutic effect were evaluated in vitro and in vivo. Results revealed that this nanoagent had excellent biocompatibility and enhanced the photothermal effect compared to blue nanocubes (PBs) and polydopamine-capped Prussian blue nanocubes (PB@PDA, PBPs). Therefore, our study may open a new path for the production of PB-based nanocomposites as theranostic nanoagents for imaging-guided photothermal cancer treatment.
- 24 February 2021
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 11 (15) , 8420-8429
Open AccessFluorescence imaging-guided cancer photothermal therapy using polydopamine and graphene quantum dot-capped Prussian blue nanocubes
In recent years, imaging-guided photothermal tumor ablation has attracted intense research interest as one of the most exciting strategies for cancer treatment. Herein, we prepared polydopamine and graphene quantum dot-capped Prussian blue nanocubes (PB@PDA@GQDs, PBPGs) with high photothermal conversion efficiency and excellent fluorescence performance for imaging-guided cancer treatment. Transmission electron microscopy (TEM), UV-vis absorption spectroscopy (UV-vis), fluorescence spectroscopy, and X-ray photoelectron spectroscopy (XPS) were employed to characterize their morphology and structures. The photothermal conversion efficiency and therapeutic effect were evaluated in vitro and in vivo. Results revealed that this nanoagent had excellent biocompatibility and enhanced the photothermal effect compared to blue nanocubes (PBs) and polydopamine-capped Prussian blue nanocubes (PB@PDA, PBPs). Therefore, our study may open a new path for the production of PB-based nanocomposites as theranostic nanoagents for imaging-guided photothermal cancer treatment.
- Open Access
- 8 November 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (66) , 37623-37630
Synthesis of novel cyclodextrin-modified reduced graphene oxide composites by a simple hydrothermal method
The rGO@CD@PEG@FA nanocomposite showed the stimulative effect of heat, pH response, and sustained drug release for cancer therapy
- 8 November 2018
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 8 (66) , 37623-37630
Open AccessSynthesis of novel cyclodextrin-modified reduced graphene oxide composites by a simple hydrothermal method
The rGO@CD@PEG@FA nanocomposite showed the stimulative effect of heat, pH response, and sustained drug release for cancer therapy
- Open Access
- 18 May 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (43) , 26704-26709
Synthesis, characterization and application of TiO 2 /Ag recyclable SERS substrates
In this paper, rutile and anatase TiO 2 /Ag nanocomposites were prepared by a facile and green photochemical method.
- 18 May 2017
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 7 (43) , 26704-26709
Open AccessSynthesis, characterization and application of TiO 2 /Ag recyclable SERS substrates
In this paper, rutile and anatase TiO 2 /Ag nanocomposites were prepared by a facile and green photochemical method.